Endocrine Abstracts

The usefulness of bone mineral density (BMD) and bone turnover markers measurements to assess the renal osteodystrophy in patients with chronic kidney disease, stage 5 (CKD5) are not well determined.The aim was to analyze BMD, serum levels of parathyroid hormone (PTH) and bone turnover markers in dialysis patients. We examined 45 patients (20 f,25 m; age 45.1±10.8 yrs; age at dialysis onset 40.3±12.3 yrs; dialysis duration 5.0±4.0 yrs). BM...